tiprankstipranks
Trending News
More News >
Telo Genomics Corp (TSE:TELO)
:TELO
Canadian Market

Telo Genomics Corp (TELO) Financial Statements

Compare
21 Followers

Telo Genomics Corp Financial Overview

Telo Genomics Corp's market cap is currently C$4.52M. The company's EPS TTM is C$; its P/E ratio is -1.66; Telo Genomics Corp is scheduled to report earnings on November 25, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 23Dec 22Dec 21Dec 20
Income Statement
Total RevenueC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross ProfitC$ -14.45KC$ -39.54KC$ -33.11KC$ -56.96KC$ -62.23K
Operating IncomeC$ -2.70MC$ -2.72MC$ -2.82MC$ -2.15MC$ -1.25M
EBITDAC$ -2.69MC$ -2.67MC$ -2.78MC$ -2.05MC$ -1.01M
Net IncomeC$ -2.72MC$ -2.71MC$ -2.82MC$ -2.11MC$ -1.07M
Balance Sheet
Cash & Short-Term InvestmentsC$ 789.29KC$ 796.02KC$ 2.67MC$ 2.69MC$ 3.64M
Total AssetsC$ 911.30KC$ 965.64KC$ 2.93MC$ 2.83MC$ 3.84M
Total DebtC$ 0.00C$ 0.00C$ 32.50KC$ 40.00KC$ 40.00K
Net DebtC$ -789.29KC$ -796.02KC$ -2.64MC$ -2.65MC$ -3.60M
Total LiabilitiesC$ 396.32KC$ 375.59KC$ 312.87KC$ 230.07KC$ 153.66K
Stockholders' EquityC$ 514.98KC$ 590.06KC$ 2.61MC$ 2.60MC$ 3.69M
Cash Flow
Free Cash FlowC$ -2.33MC$ -2.46MC$ -2.70MC$ -1.82MC$ -1.11M
Operating Cash FlowC$ -2.33MC$ -2.46MC$ -2.63MC$ -1.79MC$ -1.10M
Investing Cash FlowC$ -3.25KC$ -5.12KC$ -69.06KC$ -25.19KC$ -9.31K
Financing Cash FlowC$ 2.33MC$ 587.05KC$ 2.68MC$ 876.65KC$ 3.83M
Currency in CAD

Telo Genomics Corp Earnings and Revenue History

Telo Genomics Corp Debt to Assets

Telo Genomics Corp Cash Flow

Telo Genomics Corp Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.